Covaxin 50% effective against symptomatic Covid in real-world, finds Lancet study
The latest research assessed 2,714 hospital workers of AIIMS through one month
Source: telegraphindia.com
Page 31 - Additional Professor News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Additional Professor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Additional Professor Today - Breaking & Trending Today
Covaxin shows 50% effectiveness against symptomatic Covid-19: Lancet
According to the study, Covaxin is 50% effective against the symptomatic Covid-19.
Source: indiatoday.in
Covaxin shows 50% effectiveness against Covid Delta variant: Lancet study
Two doses of Covaxin are 50 per cent effective against the Delta variant of coronavirus disease, according to the first real-world assessment of India's indigenous Covid-19 vaccine published in The Lancet Infectious Diseases journal.
Source: deccanherald.com
Covaxin shows 50% effectiveness against symptomatic COVID in real-world assessment: Lancet study
Covaxin, Covaxin effectiveness, Covaxin symptomatic, COVID, Covaxin real world assessment, Covaxin Lancet study, latest coronavirus pandemic news updates, Covaxin news, Covaxin latest news updates
Source: indiatvnews.com
Covaxin offered only 50% protection against Covid during 2nd wave in India
Two-dose of Covaxin, developed by Hyderabad-based Bharat Biotech, provided only 50 per cent protection against the Covid-19 infection during the second wave of the pandemic in India, according to the first real-world assessment published in The ...
Source: prokerala.com